黑料社

David Panneton joined 黑料社 in January 2017 and serves as vice president of global business units for 黑料社 Healthcare’s diagnostics, life sciences and Japanese businesses. In his present role, David has his teams focused on accelerating customer growth opportunities through emerging technologies in the domains of diagnostic imaging, proteomics & genomics, point-of-care and molecular diagnostics. An industry veteran with thirty years of experience and deep domain knowledge in both biopharma and diagnostics, David has successfully developed and executed personalized medicine programs bringing together diagnostics and treatment therapies in the disease areas of HIV, hepatitis, and cancer.